Literature DB >> 23114602

Molecular pathogenesis and clinical management of Fanconi anemia.

Younghoon Kee1, Alan D D'Andrea.   

Abstract

Fanconi anemia (FA) is a rare genetic disorder associated with a high frequency of hematological abnormalities and congenital anomalies. Based on multilateral efforts from basic scientists and clinicians, significant advances in our knowledge of FA have been made in recent years. Here we review the clinical features, the diagnostic criteria, and the current and future therapies of FA and describe the current understanding of the molecular basis of the disease.

Entities:  

Mesh:

Year:  2012        PMID: 23114602      PMCID: PMC3484428          DOI: 10.1172/JCI58321

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  118 in total

1.  BACH1 is critical for homologous recombination and appears to be the Fanconi anemia gene product FANCJ.

Authors:  Rachel Litman; Min Peng; Zhe Jin; Fan Zhang; Junran Zhang; Simon Powell; Paul R Andreassen; Sharon B Cantor
Journal:  Cancer Cell       Date:  2005-09       Impact factor: 31.743

2.  Reduced fertility and hypersensitivity to mitomycin C characterize Fancg/Xrcc9 null mice.

Authors:  Mireille Koomen; Ngan C Cheng; Henri J van de Vrugt; Barbara C Godthelp; Martin A van der Valk; Anneke B Oostra; Malgorzata Z Zdzienicka; Hans Joenje; Fré Arwert
Journal:  Hum Mol Genet       Date:  2002-02-01       Impact factor: 6.150

Review 3.  Fanconi's anaemia and pregnancy.

Authors:  B P Alter; C L Frissora; D S Halpérin; M H Freedman; U Chitkara; E Alvarez; L Lynch; B Adler-Brecher; A D Auerbach
Journal:  Br J Haematol       Date:  1991-03       Impact factor: 6.998

4.  Mutation of the RAD51C gene in a Fanconi anemia-like disorder.

Authors:  Fiona Vaz; Helmut Hanenberg; Beatrice Schuster; Karen Barker; Constanze Wiek; Verena Erven; Kornelia Neveling; Daniela Endt; Ian Kesterton; Flavia Autore; Franca Fraternali; Marcel Freund; Linda Hartmann; David Grimwade; Roland G Roberts; Heiner Schaal; Shehla Mohammed; Nazneen Rahman; Detlev Schindler; Christopher G Mathew
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

5.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

Review 6.  Androgens and liver tumors: Fanconi's anemia and non-Fanconi's conditions.

Authors:  Isela Velazquez; Blanche P Alter
Journal:  Am J Hematol       Date:  2004-11       Impact factor: 10.047

7.  Spontaneous chromosome aberrations in Fanconi's anemia patients are located at fragile sites and acute myeloid leukemia breakpoints.

Authors:  A Fundia; N Gorla; I Larripa
Journal:  Hereditas       Date:  1994       Impact factor: 3.271

8.  Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype.

Authors:  Jung Min Kim; Kalindi Parmar; Min Huang; David M Weinstock; Carrie Ann Ruit; Jeffrey L Kutok; Alan D D'Andrea
Journal:  Dev Cell       Date:  2009-02       Impact factor: 12.270

Review 9.  Molecular pathogenesis of Fanconi anemia: recent progress.

Authors:  Toshiyasu Taniguchi; Alan D D'Andrea
Journal:  Blood       Date:  2006-02-21       Impact factor: 22.113

10.  Clinical and molecular characteristics of squamous cell carcinomas from Fanconi anemia patients.

Authors:  Hester J T van Zeeburg; Peter J F Snijders; Thijs Wu; Eliane Gluckman; Jean Soulier; Jordi Surralles; Maria Castella; Jacqueline E van der Wal; Johan Wennerberg; Joseph Califano; Eunike Velleuer; Ralf Dietrich; Wolfram Ebell; Elisabeth Bloemena; Hans Joenje; C René Leemans; Ruud H Brakenhoff
Journal:  J Natl Cancer Inst       Date:  2008-11-11       Impact factor: 13.506

View more
  117 in total

Review 1.  Applications of high-throughput DNA sequencing to benign hematology.

Authors:  Vijay G Sankaran; Patrick G Gallagher
Journal:  Blood       Date:  2013-09-10       Impact factor: 22.113

Review 2.  Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers.

Authors:  Ronald S Cheung; Toshiyasu Taniguchi
Journal:  Int J Hematol       Date:  2017-06-19       Impact factor: 2.490

3.  Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations.

Authors:  Lise B Ahlborn; Ane Y Steffensen; Lars Jønson; Malene Djursby; Finn C Nielsen; Anne-Marie Gerdes; Thomas V O Hansen
Journal:  Fam Cancer       Date:  2015-03       Impact factor: 2.375

4.  Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.

Authors:  Hebist Berhane; Michael W Epperly; Julie Goff; Ronny Kalash; Shaonan Cao; Darcy Franicola; Xichen Zhang; Donna Shields; Frank Houghton; Hong Wang; Peter Wipf; Kalindi Parmar; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-01-07       Impact factor: 2.841

Review 5.  Small-molecule inhibitors of the Myc oncoprotein.

Authors:  Steven Fletcher; Edward V Prochownik
Journal:  Biochim Biophys Acta       Date:  2014-03-19

6.  Bloom syndrome radials are predominantly non-homologous and are suppressed by phosphorylated BLM.

Authors:  Nichole Owen; James Hejna; Scott Rennie; Asia Mitchell; Amy Hanlon Newell; Navid Ziaie; Robb E Moses; Susan B Olson
Journal:  Cytogenet Genome Res       Date:  2015-02-28       Impact factor: 1.636

7.  Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Authors:  Hebist Berhane; Ashwin Shinde; Ronny Kalash; Karen Xu; Michael W Epperly; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-06-16       Impact factor: 2.841

8.  mTOR regulates DNA damage response through NF-κB-mediated FANCD2 pathway in hematopoietic cells.

Authors:  J Li; W Du; S Zhang; F Guo; M O'Connor; G Thomas; S Kozma; B Zingarelli; Q Pang; Y Zheng
Journal:  Leukemia       Date:  2013-03-29       Impact factor: 11.528

9.  The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression.

Authors:  Caroline C Huard; Cédric S Tremblay; Audrey Magron; Georges Lévesque; Madeleine Carreau
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-27       Impact factor: 11.205

Review 10.  Familial myelodysplastic syndrome/acute leukemia syndromes: a review and utility for translational investigations.

Authors:  Allison H West; Lucy A Godley; Jane E Churpek
Journal:  Ann N Y Acad Sci       Date:  2014-01-27       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.